Literature DB >> 17601862

Clinical research with economically disadvantaged populations.

Colleen C Denny1, Christine Grady.   

Abstract

Concerns about exploiting the poor or economically disadvantaged in clinical research are widespread in the bioethics community. For some, any research that involves economically disadvantaged individuals is de facto ethically problematic. The economically disadvantaged are thought of as "vulnerable" [corrected] to exploitation, impaired decision making, or both, thus requiring either special protections or complete exclusion from research. A closer examination of the worries about vulnerabilities among the economically disadvantaged reveals that some of these worries are empirically or logically untenable, while others can be better resolved by improved study designs than by blanket exclusion of poorer individuals from research participation. The scientific objective to generate generalisable results and the ethical objective to fairly distribute both the risks and benefits of research oblige researchers not to unnecessarily bar economically disadvantaged subjects from clinical research participation.

Mesh:

Year:  2007        PMID: 17601862      PMCID: PMC2598135          DOI: 10.1136/jme.2006.017681

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  20 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  On paying money to research subjects: 'due' and 'undue' inducements.

Authors:  Ruth Macklin
Journal:  IRB       Date:  1981-05

Review 3.  Enrolling the uninsured in clinical trials: an ethical perspective.

Authors:  Christine Pace; Franklin G Miller; Marion Danis
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

4.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Postgrad Med       Date:  2002 Jul-Sep       Impact factor: 1.476

5.  The invisible vulnerable: the economically and educationally disadvantaged subjects of clinical research.

Authors:  T Howard Stone
Journal:  J Law Med Ethics       Date:  2003       Impact factor: 1.718

Review 6.  Development of a theoretical construct for risk and vulnerability from six empirical studies.

Authors:  Jeanne M Leffers; Diane C Martins; Margaret M McGrath; Deborah Godfrey Brown; Judith Mercer; Mary C Sullivan; Paula Viau
Journal:  Res Theory Nurs Pract       Date:  2004       Impact factor: 0.688

7.  Where techno-science meets poverty: medical research and the economy of blood in The Gambia, West Africa.

Authors:  James Fairhead; Melissa Leach; Mary Small
Journal:  Soc Sci Med       Date:  2006-04-21       Impact factor: 4.634

8.  Quality of informed consent in cancer clinical trials: a cross-sectional survey.

Authors:  S Joffe; E F Cook; P D Cleary; J W Clark; J C Weeks
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

9.  Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.

Authors:  Scott D Halpern; Jason H T Karlawish; David Casarett; Jesse A Berlin; David A Asch
Journal:  Arch Intern Med       Date:  2004-04-12

10.  Bioethics, vulnerability, and protection.

Authors:  Ruth Macklin
Journal:  Bioethics       Date:  2003-10       Impact factor: 1.898

View more
  19 in total

1.  Promoting human subjects training for place-based communities and cultural groups in environmental research: curriculum approaches for graduate student/faculty training.

Authors:  Dianne Quigley
Journal:  Sci Eng Ethics       Date:  2014-01-16       Impact factor: 3.525

2.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

3.  Factors associated with past research participation among low-income persons living with HIV.

Authors:  Jacquelyn Slomka; Georgios Kypriotakis; John Atkinson; Pamela M Diamond; Mark L Williams; Damon J Vidrine; Roberto Andrade; Roberto Arduino
Journal:  AIDS Patient Care STDS       Date:  2012-06-11       Impact factor: 5.078

4.  Comprehension and informed consent: assessing the effect of a short consent form.

Authors:  Leanne Stunkel; Meredith Benson; Louise McLellan; Ninet Sinaii; Gabriella Bedarida; Ezekiel Emanuel; Christine Grady
Journal:  IRB       Date:  2010 Jul-Aug

5.  Ethical Issues in Conducting Cross-Cultural Research in Low-Income Countries: A Pakistani Perspective.

Authors:  Asma Fazal
Journal:  Asian Bioeth Rev       Date:  2021-11-06

6.  Protecting and respecting the vulnerable: existing regulations or further protections?

Authors:  Stephanie R Solomon
Journal:  Theor Med Bioeth       Date:  2013-02

Review 7.  The clinical investigator-subject relationship: a contextual approach.

Authors:  David B Resnik
Journal:  Philos Ethics Humanit Med       Date:  2009-12-03       Impact factor: 2.464

8.  Compensation in clinical research: The debate continues.

Authors:  Mansi Pandya; Chetna Desai
Journal:  Perspect Clin Res       Date:  2013-01

9.  Ethics committee member: Reviewing the 'Ethics' in clinical research.

Authors:  Raakhi Tripathi
Journal:  Perspect Clin Res       Date:  2013-01

10.  Assessing the quality of informed consent in a resource-limited setting: a cross-sectional study.

Authors:  Ronald Kiguba; Paul Kutyabami; Stephen Kiwuwa; Elly Katabira; Nelson K Sewankambo
Journal:  BMC Med Ethics       Date:  2012-08-21       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.